Clinical Trials Browser

Phase 2 × HER2-positive Gastric Cancer × Drug Therapy × Clear all

NCT05311189 2022-04-05

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

HER2-positive Gastric Cancer